A detailed history of Northwestern Mutual Wealth Management CO transactions in Ligand Pharmaceuticals Inc stock. As of the latest transaction made, Northwestern Mutual Wealth Management CO holds 583 shares of LGND stock, worth $64,456. This represents 0.0% of its overall portfolio holdings.

Number of Shares
583
Previous 566 3.0%
Holding current value
$64,456
Previous $47,000 23.4%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$82.7 - $110.11 $1,405 - $1,871
17 Added 3.0%
583 $58,000
Q2 2024

Aug 15, 2024

SELL
$68.53 - $87.91 $1,096 - $1,406
-16 Reduced 2.75%
566 $47,000
Q1 2024

May 15, 2024

BUY
$68.64 - $89.2 $1,098 - $1,427
16 Added 2.83%
582 $42,000
Q3 2023

Nov 14, 2023

SELL
$58.86 - $72.67 $9,417 - $11,627
-160 Reduced 22.04%
566 $33,000
Q3 2022

Nov 14, 2022

SELL
$0.01 - $107.56 $1 - $16,134
-150 Reduced 17.12%
726 $63,000
Q2 2022

Aug 04, 2022

SELL
$74.52 - $117.06 $74 - $117
-1 Reduced 0.11%
876 $78,000
Q1 2022

May 09, 2022

BUY
$94.99 - $151.56 $94 - $151
1 Added 0.11%
877 $99,000
Q4 2021

Feb 03, 2022

BUY
$127.69 - $165.85 $82,360 - $106,973
645 Added 279.22%
876 $135,000
Q3 2021

Nov 15, 2021

BUY
$102.33 - $144.73 $4,911 - $6,947
48 Added 26.23%
231 $32,000
Q2 2020

Aug 14, 2020

SELL
$68.28 - $123.65 $546 - $989
-8 Reduced 4.19%
183 $20,000
Q4 2019

Feb 13, 2020

SELL
$96.94 - $113.59 $678 - $795
-7 Reduced 3.54%
191 $20,000
Q3 2019

Nov 12, 2019

BUY
$86.25 - $120.16 $603 - $841
7 Added 3.66%
198 $20,000
Q2 2019

Aug 12, 2019

BUY
$107.38 - $129.34 $859 - $1,034
8 Added 4.37%
191 $22,000
Q1 2019

May 10, 2019

SELL
$105.93 - $142.47 $741 - $997
-7 Reduced 3.68%
183 $23,000
Q2 2018

Aug 10, 2018

BUY
$150.77 - $207.98 $28,646 - $39,516
190 New
190 $39,000
Q3 2017

Nov 07, 2017

SELL
$120.91 - $137.94 $3,385 - $3,862
-28 Closed
0 $0
Q2 2017

Aug 10, 2017

BUY
N/A
28
28 $3,000

Others Institutions Holding LGND

About LIGAND PHARMACEUTICALS INC


  • Ticker LGND
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 16,882,800
  • Market Cap $1.87B
  • Description
  • Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...
More about LGND
Track This Portfolio

Track Northwestern Mutual Wealth Management CO Portfolio

Follow Northwestern Mutual Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.